本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Entrada Therapeutics, Inc.

6.80
+0.38005.92%
盤後6.48-0.3200-4.71%19:30 EDT
成交量:29.18萬
成交額:193.09萬
市值:2.64億
市盈率:-1.71
高:6.81
開:6.49
低:6.29
收:6.42
52周最高:16.45
52周最低:5.02
股本:3,882.06萬
流通股本:2,271.93萬
量比:0.70
換手率:1.28%
股息:- -
股息率:- -
每股收益(TTM):-3.9676
每股收益(LYR):-3.4746
淨資產收益率:-54.09%
總資產收益率:-29.20%
市淨率:1.13
市盈率(LYR):-1.96

資料載入中...

2024/06/26

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/06/24

重要事件披露

Form 8-K - Current report
2024/06/24

重要事件披露

Form 8-K - Current report
2024/06/14

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/06/13

重要事件披露

Form 8-K - Current report
2024/05/17

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/05/17

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/05/07

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/05/07

重要事件披露

Form 8-K - Current report
2024/05/01

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/04/30

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/04/26

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/04/26

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/04/25

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/04/24

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/04/19

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/04/19

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/04/18

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/04/17

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/04/16

關聯方擬減持公告

Form 144 - Report of proposed sale of securities